Project details
- Project period
- 1 Nov 2025 - 31 Oct 2030
- Total cost
- €5 325 102,49
- Global Health EDCTP3 funding
- €5 325 102,49
- Call identifier
- HORIZON_HORIZON-JU-GH-EDCTP3-2024-01-02-two-stage
- Status
- In progress
- Project type
- Research and Innovation Actions (RIA)
- Disease area
- Malaria
- Intervention type
- VaccinesTherapies
Consortium map
Coordinator
LIVERPOOL SCHOOL OF TROPICAL MEDICINE
- Location
- LIVERPOOL 3, United Kingdom
- EU contribution
- €922 043,74
- Total cost
- €1 194 407,47
Scientific project leader
TRAINING & RESEARCH UNIT OF EXCELLENCE LIMITED
Location: Blantyre, Malawi
Beneficiaries
TRAINING & RESEARCH UNIT OF EXCELLENCE LIMITED
- Location
- Blantyre, Malawi
- EU contribution
- €1 827 806,08
- Total cost
- €1 827 806,08
MAKERERE UNIVERSITY
- Location
- Kampala, Uganda
- EU contribution
- €337 936,33
- Total cost
- €337 936,33
GLOBAL HEALTH UGANDA LIMITED
- Location
- KAMPALA, Uganda
- EU contribution
- €895 423,54
- Total cost
- €895 423,54
UNIVERSITETET I BERGEN
- Location
- Bergen, Norway
- EU contribution
- €221 716,69
- Total cost
- €221 716,69
KENYA MEDICAL RESEARCH INSTITUTE
- Location
- Nairobi, Kenya
- EU contribution
- €847 812,38
- Total cost
- €847 812,38
Related projects
AI detection of parasite infectionsThe MultiplexAI project is developing an easy-to-use add-on for conventional microscopes that deploys artificial intelligence (AI) models to detect...
Disrupting mosquito feeding to prevent malariaThe LASR project is testing whether a newly developed mosquito repellent can reduce the community burden of malaria infections.
The 2nd Generation Malaria Vaccine Consortium (MVC-2G) will build on the programmatic use of the first-generation Plasmodium falciparum vaccine, R21 with Matrix-M™, and accelerate the...